journal article·2023-06-14

Dual-Action Heteromultivalent Glycopolymers Stringently Block and Arrest Influenza A Virus Infection In Vitro and Ex Vivo

Badri Parshad, Marlena N. Schlecht, Morris Baumgardt, Kai Ludwig, Chuanxiong Nie, Agustina Rimondi, Katja Hönzke, Stefano Angioletti-Uberti, Vinod Khatri, Paul Schneider, Andreas Herrmann, Rainer Haag, Andreas C. Hocke, Thorsten Wolff, Sumati Bhatia

Nano Letters· Volume 23· Issue 11
Publisher page

Abstract

Here, we demonstrate the concerted inhibition of different influenza A virus (IAV) strains using a low-molecular-weight dual-action linear polymer. The 6′-sialyllactose and zanamivir conjugates of linear polyglycerol are optimized for simultaneous targeting of hemagglutinin and neuraminidase on the IAV surface. Independent of IAV subtypes, hemagglutination inhibition data suggest better adsorption of the heteromultivalent polymer than homomultivalent analogs onto the virus surface. Cryo-TEM images imply heteromultivalent compound-mediated virus aggregation. The optimized polymeric nanomaterial inhibits >99.9% propagation of various IAV strains 24 h postinfection in vitro at low nM concentrations and is up to 10000× more effective than the commercial zanamivir drug. In a human lung ex vivo multicyclic infection setup, the heteromultivalent polymer outperforms the commercial drug zanamivir and homomultivalent analogs or their physical mixtures. This study authenticates the translational potential of the dual-action targeting approach using small polymers for broad and high antiviral efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Influenza Virus Research Studies · Respiratory viral infections research · Immune Cell Function and Interaction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institut für Chemie und Biochemie Organische Chemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany

Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, United States

Unit 17, Influenza and Other Respiratory Viruses, Robert Koch-Institut, Seestraße 10, 13353 Berlin, Germany

Medical Clinic III, Division of Nephrology, Medizinische Fakultät Carl Gustav Carus an der TU Dresden, Fiedlerstr. 40, 01307 Dresden, Germany

Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité−Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany

Forschungszentrum für Elektronenmikroskopie and Core Facility BioSupraMol, Institut für Chemie und Biochemie, Freie Universität Berlin, Fabeckstr. 36a, 14195 Berlin, Germany

Department of Materials, Imperial College London, London SW7 2AZ, U.K.

Department for Thoracic Surgery, DRK Clinics, 13359 Berlin, Germany

Funding

Bundesministerium für Bildung und Forschung · Deutsche Forschungsgemeinschaft · Berlin University Alliance · Einstein Stiftung Berlin · Alexander von Humboldt-Stiftung

References (41)

Show source-provided references
1. Influenza (Seasonal). World Health Organization, January 12, 2023.https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).
2. 10.1136/bmj.p51010.1136/bmj.p510 ↗
3. 10.1038/s41422-021-00473-110.1038/s41422-021-00473-1 ↗
4. 10.1016/S0140-6736(20)31052-710.1016/S0140-6736(20)31052-7 ↗
5. 10.1093/ije/dyab08110.1093/ije/dyab081 ↗
6. 10.1016/j.tim.2019.08.01010.1016/j.tim.2019.08.010 ↗
7. 10.7554/eLife.4376410.7554/eLife.43764 ↗
8. 10.1039/C9SC05149J10.1039/C9SC05149J ↗
9. 10.3389/fmicb.2019.0003910.3389/fmicb.2019.00039 ↗
10. 10.1371/journal.ppat.100062110.1371/journal.ppat.1000621 ↗
11. 10.1002/smll.20200721410.1002/smll.202007214 ↗
12. 10.1186/1743-422X-10-32110.1186/1743-422X-10-321 ↗
13. 10.1021/jm950294c10.1021/jm950294c ↗
14. 10.2807/1560-7917.ES.2017.22.3.3044510.2807/1560-7917.ES.2017.22.3.30445 ↗
15. 10.1021/jm00021a00710.1021/jm00021a007 ↗
16. 10.1038/nnano.2016.18110.1038/nnano.2016.181 ↗
17. 10.1002/smll.20100134910.1002/smll.201001349 ↗
18. 10.1038/s41565-020-0660-210.1038/s41565-020-0660-2 ↗
19. 10.1002/anie.20200614510.1002/anie.202006145 ↗
20. 10.4155/fmc-2020-020510.4155/fmc-2020-0205 ↗
21. 10.1016/j.bmc.2013.01.02810.1016/j.bmc.2013.01.028 ↗
22. 10.1021/bi00447a01810.1021/bi00447a018 ↗
23. 10.1021/acs.jmedchem.1c0079410.1021/acs.jmedchem.1c00794 ↗
24. 10.1016/j.biomaterials.2017.05.02810.1016/j.biomaterials.2017.05.028 ↗
25. 10.1021/bm500260810.1021/bm5002608 ↗
26. 10.1073/pnas.060761410310.1073/pnas.0607614103 ↗
27. 10.1016/j.cell.2018.10.05610.1016/j.cell.2018.10.056 ↗
28. 10.1248/cpb.51.138610.1248/cpb.51.1386 ↗
29. 10.1063/1.474810010.1063/1.4748100 ↗
30. 10.1063/1.477580610.1063/1.4775806 ↗
31. 10.1002/embj.20138744210.1002/embj.201387442 ↗
32. 10.1128/JCM.43.8.4139-4146.200510.1128/JCM.43.8.4139-4146.2005 ↗
33. 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-310.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 ↗
34. 10.1021/ja511408410.1021/ja5114084 ↗
35. 10.1073/pnas.100310310710.1073/pnas.1003103107 ↗
36. 10.1021/jm00046a02710.1021/jm00046a027 ↗
37. 10.1021/ja411582t10.1021/ja411582t ↗
38. 10.1021/acs.accounts.6b0018110.1021/acs.accounts.6b00181 ↗
39. 10.1039/D0MA00916D10.1039/D0MA00916D ↗
40. 10.1016/j.colsurfb.2016.08.05310.1016/j.colsurfb.2016.08.053 ↗
41. 10.1084/jem.2018162410.1084/jem.20181624 ↗